Anti-Inflammatory Effects of Macrophilin-lnteracting Drugs in Animal Models of Irritant and Allergic Contact...

Area of Science:

• Immunology
• Pharmacology
• Dermatology

Background:

• FK 506 and rapamycin are macrolide antibiotics known for potent immunosuppressive effects.
• Both compounds bind to macrophilin-12, an immunophilin.
• Rapamycin exhibits a distinct mode of action on T cells, not affecting lymphokine transcription.

Purpose of the Study:

• To compare the anti-inflammatory effects of FK 506 and rapamycin in mouse models of irritant and allergic contact dermatitis.
• To evaluate the efficacy of topical and oral administration of these macrolide antibiotics.

Main Methods:

• Testing FK 506 and rapamycin in mouse models of irritant dermatitis (topical application).
• Assessing FK 506 and rapamycin in allergic contact dermatitis models (topical and oral application) in mice and domestic pigs.
• Comparing efficacy against corticosteroids in allergic contact dermatitis models.

Main Results:

• Both FK 506 and rapamycin showed moderate topical activity (0.4-3.6%) in irritant dermatitis.
• Topical FK 506 (0.01-0.1%) was highly effective in allergic contact dermatitis, surpassing corticosteroids.
• Rapamycin was inactive in allergic contact dermatitis models.
• Oral FK 506 was significantly active, while oral rapamycin was inactive in mice.

Conclusions:

• FK 506 and rapamycin possess distinct pharmacological properties despite structural similarities and a common receptor.
• These differences likely stem from their varied mechanisms of action.
• FK 506 demonstrates superior anti-inflammatory efficacy, particularly in allergic contact dermatitis, compared to rapamycin.